"Ballarat Day Procedure Centre provides patients with the highest level of care, effective treatment and sound management. It is the prime objective of the Centre to provide quality care in a safe, skilled, caring and supportive environment, which safeguards the privacy and rights of our patients and their families."

During the past decade, Ballarat Day Procedure Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ballarat Day Procedure Centre" are "Renal Cell Cancer" (1 trials) and "Urothelial Cancer" (1 trials). Many other conditions were trialed in "Ballarat Day Procedure Centre" in a lesser frequency.

Most popular intervention types in "Ballarat Day Procedure Centre" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Avelumab (MSB0010718C)" (1 trials), "Axitinib (AG-013736)" (1 trials), "Best Supportive Care" (1 trials) and "Following the planned interim analysis for this study: Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ballarat Day Procedure Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ballarat Day Procedure Centre". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ballarat Day Procedure Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ballarat Day Procedure Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".